C2L

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 59 mg dose 59 Phase 2a trial 58 Menerba 57 CoFactor 57 Phase 2b study 57 adalimumab 57 PROMACTA 56 ISIS # 56 eltrombopag 56 GVAX 56 azacitidine 56 CRx 56 teriparatide 55 HGS ETR1 55 FTY# 55 telbivudine 55 phase IIb 55 JANUVIA 54 cethromycin 54 budesonide 54 alendronate 54 phase IIa 54 tiotropium 54 NGX# 54 lacosamide 54 Phase IIb 54 Pharmacokinetic 54 antithrombotic 54 sustained virologic response 53 efficacy 53 Phase IIb clinical 53 HspE7 53 Phase 1b 53 OXi# 53 biologic therapy 53 Phase IIa trial 53 picoplatin 53 CA4P 53 LEVADEX 53 PXD# 53 PEG INTRON 53 elagolix 53 Phase IIa clinical 53 mg doses 53 peginterferon alfa 2b 52 mg d 52 dose escalation 52 ZYBRESTAT 52 Phase 2b trial 52 INCB# [002] 52 phase 2a 52 PF # [001] 52 Phase 2a clinical 52 IMGN# 52 donepezil 52 talactoferrin 52 lubiprostone 52 bosentan 52 Phase 1b clinical 51 tolerated dose MTD 51 ustekinumab 51 FOLFOX 51 temsirolimus 51 Phase 2b clinical 51 Empatic 51 CYT# 51 pharmacodynamic 51 docetaxel 51 dose escalation trial 51 Phase 2a 51 dosing regimens 50 monotherapy 50 Efficacy 50 Serdaxin 50 placebo controlled 50 celecoxib 50 quetiapine 50 antiplatelet 50 vinorelbine 50 placebo controlled trials 50 Adlea 50 Phase IIa 50 plus ribavirin 50 fluconazole 50 investigational compound 50 Alpharadin 50 Zenvia 50 GRN#L 50 pharmacokinetic profile 50 dosing 49 non inferiority 49 safety tolerability pharmacokinetics 49 oral bioavailability 49 Tolerability 49 tolerability profile 49 rivaroxaban 49 pharmacodynamics 49 Phase Ib 49 ranolazine 48 Phase III trials 48 pharmacokinetic properties

Back to home page